Gene · 7994
KAT6A: lysine acetyltransferase 6A
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. KAT6A: lysine acetyltransferase 6A. Genes, record 7994. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7994
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92794 | Histone acetyltransferase KAT6A | 2,004 | 21 | Ensembl, GeneID, HGNC |
Source UniProt
Patents47
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 2512 | Q92794 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2102 | Q92794 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15194 | Q92794 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2102 | Q92794 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2512 | Q92794 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15194 | Q92794 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15194 | Q92794 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15033 | Q92794 | Espacenet |
| JP 2023549761 A | 2023-11-29 | 248 | Q92794 | Espacenet |
| EP 4223770 A2 | 2023-08-09 | 42 | Q92794 | Espacenet |
1 to 10 of 47
See all 47 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,279
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | KAT6A papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 9 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 7 | 2025 |
| R01HD106051 | Quantitative mass spectrometry for comprehending epigenetic mechanisms in a new underlying neurological developmental disorder | 7 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 5 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 5 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 5 | 2025 |
| P30CA138313 | Medical University of South Carolina - Cancer Center Support Grant | 5 | 2025 |
| P50CA217694 | SPORE in Soft Tissue Sarcoma | 5 | 2025 |
1 to 10 of 1,279Source NIH's project files
See all 1,279 nih grantsPapers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KAT6A inhibitor-loaded and anti-PD-L1-coated manganese metal-organic framework nanoplatform for enhanced colorectal cancer immunotherapy via cGAS-STING activation. | Int J Pharm X | 2026 | 42756777 | PubTator, text mining | PubMed |
| Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia. | Genes Chromosomes Cancer | 2026 | 42704008 | PubTator, text mining | PubMed |
| KAT6A-inhibitor co-crystal structures: tackling a challenging crystallization target via two alternative approaches. | Acta Crystallogr D Struct Biol | 2026 | 42657771 | PubTator, text mining | PubMed |
| Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery. | ACS Med Chem Lett | 2026 | 42621538 | PubTator, text mining | PubMed |
| An Explicit Interaction-Prompted Diffusion Framework for High-Fidelity 3D Molecular Generation. | J Am Chem Soc | 2026 | 42619129 | PubTator, text mining | PubMed |
| Integrated population-based evidence, network toxicology, single-cell profiling, and in vitro studies elucidate mechanisms connecting PAHs to stroke. | Ecotoxicol Environ Saf | 2026 | 42594829 | PubTator, text mining | PubMed |
| Beyond acetylation: Evaluating the emerging biology of lysine acylation. | Cell Chem Biol | 2026 | 42586062 | PubTator, text mining | PubMed |
| OverlappING and DivergING roles of ING4 and ING5 in cancer, differentiation and development. | Front Cell Dev Biol | 2026 | 42577687 | PubTator, text mining | PubMed |
| Expanding the Hematologic Phenotype of Arboleda-Tham Syndrome: A Novel KAT6A Variant Associated With Bone Marrow Failure Requiring Hematopoietic Stem Cell Transplantation. | Pediatr Blood Cancer | 2026 | 42479970 | PubTator, text mining | PubMed |
| Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC. | Sci Rep | 2026 | 42477403 | PubTator, text mining | PubMed |
1 to 10 of 1,720
See all 1,720 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7994
GET https://conductscience.org/api/genes/v1/7994/patents?page=2